BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27499201)

  • 1. A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells.
    Howden SE; McColl B; Glaser A; Vadolas J; Petrou S; Little MH; Elefanty AG; Stanley EG
    Stem Cell Reports; 2016 Sep; 7(3):508-517. PubMed ID: 27499201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
    Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
    Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair.
    Gutschner T; Haemmerle M; Genovese G; Draetta GF; Chin L
    Cell Rep; 2016 Feb; 14(6):1555-1566. PubMed ID: 26854237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of SpCas9 to E. coli Rec A protein enhances CRISPR-Cas9 mediated gene knockout in mammalian cells.
    Lin L; Petersen TS; Jensen KT; Bolund L; Kühn R; Luo Y
    J Biotechnol; 2017 Apr; 247():42-49. PubMed ID: 28259533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
    Horii T; Hatada I
    Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
    Wu J; Hunt SD; Xue H; Liu Y; Darabi R
    Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases.
    Yang D; Scavuzzo MA; Chmielowiec J; Sharp R; Bajic A; Borowiak M
    Sci Rep; 2016 Feb; 6():21264. PubMed ID: 26887909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
    Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
    Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna.
    Kumagai H; Nakanishi T; Matsuura T; Kato Y; Watanabe H
    PLoS One; 2017; 12(10):e0186112. PubMed ID: 29045453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
    Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
    Cells; 2020 May; 9(5):. PubMed ID: 32466123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.
    Jurlina SL; Jones MK; Agarwal D; De La Toba DV; Kambli N; Su F; Martin HM; Anderson R; Wong RM; Seid J; Attaluri SV; Chow M; Wahlin KJ
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient CRISPR/Cas9-mediated transgene knockin at the H11 locus in pigs.
    Ruan J; Li H; Xu K; Wu T; Wei J; Zhou R; Liu Z; Mu Y; Yang S; Ouyang H; Chen-Tsai RY; Li K
    Sci Rep; 2015 Sep; 5():14253. PubMed ID: 26381350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
    Dettmer R; Naujok O
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
    Steinert J; Schiml S; Fauser F; Puchta H
    Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knock-in fibroblasts and transgenic blastocysts for expression of human FGF2 in the bovine β-casein gene locus using CRISPR/Cas9 nuclease-mediated homologous recombination.
    Jeong YH; Kim YJ; Kim EY; Kim SE; Kim J; Park MJ; Lee HG; Park SP; Kang MJ
    Zygote; 2016 Jun; 24(3):442-56. PubMed ID: 26197710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells.
    Tóth E; Weinhardt N; Bencsura P; Huszár K; Kulcsár PI; Tálas A; Fodor E; Welker E
    Biol Direct; 2016 Sep; 11():46. PubMed ID: 27630115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.